foxo4-dri senolytic peptide human trial 2024 2025 inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis π¨ THEY BANNED IT. Dosage:5/5mg (standard) 01_Body's needs_Energy
Pay in 4 interest-free payments of $6.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Sep 26 - Oct 1